Health care stocks were flat to higher premarket Friday, with the Health Care Select Sector SPDR Fund (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) recently inactive.
Iovance Biotherapeutics (IOVA) shares fell past 36% after the company lowered its 2025 product revenue guidance. The company also posted a wider-than-expected Q1 loss and revenue below expectations.
ANI Pharmaceuticals (ANIP) shares advanced by over 7% after the company reported higher Q1 adjusted earnings and revenue and raised its 2025 outlook.
Hims & Hers Health (HIMS) shares were down more than 4% after the company priced $870 million in 0% convertible senior notes due 2030 in a private offering to institutional investors, with closing expected on May 13.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。